ArticleCancers2024

Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.

Atsuto Mouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.